# NIH Reporter #5R01HL180429-02

NNMT Inhibition for treating heart failure

**Recipient:** University of California Los Angeles

**Award Amount:** $707,281.00
**Ceiling:** $707,281.00

**Awarded:** September 07, 2026

**Identifier:** 5R01HL180429-02

NIH grant awarded to University of California Los Angeles for research on NNMT inhibition as a treatment for heart failure, with a project duration from August 2025 to May 2029 and an estimated value of $707,281.

### Description

This is a NIH grant opportunity for research on inhibiting Nicotinamide-N-Methyl Transferase (NNMT) to treat heart failure. The project involves preclinical studies and aims to evaluate genetic and pharmacological inhibition of NNMT as a therapeutic strategy.

[View original record](https://reporter.nih.gov/search/0C83gI3MXki4-tEhFD4UKQ/project-details/11389654)